Comprehensive Phosphoproteomics Analysis

Comprehensive Phosphoproteomics Analysis – Deep Coverage, Site‑Specific Quantification, and Pathway Mapping

If you are searching for phosphoproteomics analysis, you likely need to identify and quantify phosphorylation sites on proteins to understand signaling pathway activation, kinase-substrate networks, drug response mechanisms, or disease biomarkers. Unlike standard proteomics, phosphoproteomics requires specialized enrichment, high‑sensitivity mass spectrometry, and advanced bioinformatics to localize phosphorylation sites and measure their dynamic regulation. Our laboratory offers end‑to‑end phosphoproteomics services – from phosphopeptide enrichment to deep‑coverage LC‑MS/MS, site‑specific stoichiometry, and integrated pathway analysis – using high‑field Orbitrap instruments, TiO₂/IMAC enrichment, and multiplexed TMT or label‑free quantification.

What We Analyze – Full Phosphoproteomics Scope

We do not simply report “phosphorylated proteins”. Our workflow begins with optimized protein extraction, reduction, alkylation, and enzymatic digestion (trypsin, Lys‑C, or others). Phosphopeptides are enriched using TiO₂ (titanium dioxide) or IMAC (immobilized metal affinity chromatography) columns, achieving >90% specificity. We analyze enriched samples on Thermo Orbitrap Exploris 480 or Q‑Exactive HF‑X with data‑dependent acquisition (DDA) or data‑independent acquisition (DIA). For relative quantification, we perform label‑free quantification (LFQ) or tandem mass tag (TMT) multiplexing (up to 18‑plex). We identify and localize phosphorylation sites using Sequest, Mascot, or MS‑Fragger with PTM localization probability (PhosphoRS, ptmRS) – reporting only sites with >0.75 localization confidence. For absolute phosphorylation stoichiometry (percentage of modified protein), we offer parallel reaction monitoring (PRM) with synthetic heavy phosphopeptide standards or label‑free intensity‑based estimation.

Key parameters and deliverables we routinely provide:
- Number of identified phosphopeptides and phosphosites – typically 5,000‑15,000 unique phosphosites per sample (cell lines, tissues) depending on depth.
- Site‑specific phosphorylation localization probability (>0.75) – to assign modification to exact residue.
- Relative fold changes (treated vs. control) with statistics (p‑value, FDR) – using linear models or t‑tests.
- Kinase substrate enrichment analysis (KSEA) and motif analysis – identify activated kinases based on known motifs.
- Pathway overrepresentation (KEGG, Reactome, Gene Ontology) – link phosphorylation changes to biological processes.
- Time‑course dynamics (e.g., after stimulation) with clustering (Mfuzz, k‑means) – reveal temporal regulation.
- Integration with total proteome (if provided) to calculate phosphosite‑to‑protein ratios – distinguish regulation by expression vs. phosphorylation.
- For TMT experiments: multiplexed comparison up to 18 samples in a single run – reducing missing data and technical variation.

How Deep We Go – High‑Stoichiometry Precision, Low‑Abundance Sites, and Functional Interpretation

Most routine phosphoproteomics labs detect 2,000‑5,000 sites and often miss low‑abundance regulatory phosphorylation events. Our optimized workflows achieve 8,000‑15,000 phosphosites from 1‑2 mg of protein lysate (or as little as 100 µg using micro‑flow LC). Using high‑pH reversed‑phase fractionation before enrichment, we boost coverage to >20,000 phosphosites per experiment for deep mapping. For quantification of low‑stoichiometry sites (<5% occupancy), we employ PTM‑centric data acquisition (e.g., inclusion lists of theoretical phosphopeptides) and PRM validation to achieve attomole sensitivity. Our label‑free quantification (LFQ) algorithms (MaxQuant, DIA‑NN, Spectronaut) provide coefficient of variation (CV) typically <15% between replicates. We also perform phosphorylation turnover analysis using SILAC or pulsed‑SILAC labeling to measure site‑specific synthesis and decay rates.

Our kinase activity inference goes beyond motif enrichment: we use Kinase Substrate Enrichment Analysis (KSEA) with a curated database of known kinase‑substrate pairs to calculate z‑scores and identify kinases whose substrates are globally up‑ or down‑regulated. For network analysis, we map phosphosites to interaction networks (STRING, BioGRID) and highlight signaling hubs (e.g., MAPK, PI3K/AKT, JAK‑STAT). We also offer integration with upstream regulator analysis (IPA, Ingenuity) to predict activated kinases, phosphatases, and transcription factors.

Advanced capabilities include:
- Single‑cell phosphoproteomics (limited to 50‑100 cells) using nano‑LC and carrier proteomes – for rare populations or sorted cells.
- Time‑resolved phosphoproteomics (e.g., 0, 2, 5, 10, 30 min after stimulation) – reveal early and late signaling events.
- Acquisition of phosphoproteome and total proteome from the same sample – we split the digest before enrichment.
- Phosphatase inhibitor profiling – identify off‑target effects of phosphatase inhibitors.
- Cross‑linking assisted phosphoproteomics (XL‑Phos) – map phosphorylation‑dependent protein interactions.
- Quantitative phosphoproteomics of tissue biopsies (FFPE, frozen) – with optimized extraction protocols.

We routinely achieve measurement uncertainties: site localization >99% confidence for well‑fragmented peptides; CV ≤15% for LFQ; fold change accuracy ±20% (based on spike‑in standards); 1% FDR at peptide and site level. Our methods follow best practices recommended by the Human Proteome Organization (HUPO) and CPTAC guidelines.

Why Choose Our Phosphoproteomics Services – Key Advantages

1. ISO/IEC 17025:2017 accredited and GLP‑compliant workflows – data suitable for publication and regulatory submission.
2. Deep coverage (15,000+ phosphosites per experiment) and high localization confidence (≥0.75) – we reveal rare and biologically relevant sites often missed by others.
3. Multiple quantification strategies (label‑free, TMT, SILAC, PRM) to match your experimental design – from small pilot studies to large clinical cohorts.
4. Advanced kinase activity and pathway analysis (KSEA, motif, network, IPA) – we translate phosphosite lists into testable biological hypotheses.
5. Expertise with challenging samples (FFPE, tissue microarrays, subcellular fractions, low input) – we adapt protocols to your material.
6. Fast turnaround with full data transparency – standard phosphoproteomics (label‑free, 4‑12 samples) in 10‑14 business days; TMT multiplex experiments in 15‑20 business days. You receive raw mass spectrometry data, identification tables, localization scores, quantified phosphosite matrices, and a comprehensive bioinformatics report (PCA, heatmaps, volcano plots, kinase enrichment, pathway maps).
7. Custom method development for novel organisms, tissue types, or phosphorylation motifs – we develop within 2‑3 weeks.
8. Competitive pricing for complete phosphoproteomics packages – bundling enrichment, LC‑MS/MS, database searching, and pathway analysis costs 30‑35% less than separate services.

We have successfully completed over 500 phosphoproteomics projects for pharmaceutical companies, academic laboratories, and clinical research groups. Our team includes PhD mass spectrometrists, bioinformaticians, and cell signaling experts.

Ready to Map the Phosphorylation Landscape of Your Samples?

Provide your sample type (cell line, tissue, biopsy, FFPE), treatment conditions, and biological question (e.g., “identify kinases activated by drug X”, “compare phosphosignatures between disease and control”). We will provide a free technical consultation, a recommended workflow, and a fixed‑price quote. Whether you need a single phosphoproteome snapshot or a full time‑course signaling analysis, we deliver deep, accurate, and biologically insightful phosphoproteomics data tailored to your research.